Weekly docetaxel, cisplatin, and irinotecan (TPC): results of a multicenter phase II trial in patients with metastatic esophagogastric cancer
每周一次的多西他赛、顺铂和伊立替康（TPC）方案：一项针对转移性食管胃癌患者的多中心II期临床试验结果
期刊:Annals of Oncology
影响因子:65.4
doi:10.1093/annonc/mdn658
Enzinger, P C; Ryan, D P; Clark, J W; Muzikansky, A; Earle, C C; Kulke, M H; Meyerhardt, J A; Blaszkowsky, L S; Zhu, A X; Fidias, P; Vincitore, M M; Mayer, R J; Fuchs, C S
